使用CRISPR或病毒调整基因可治愈血液疾病。 - Suppr

Suppr

超能文献

Tweaking genes with CRISPR or viruses fixes blood disorders.

作者信息

Kaiser Jocelyn

出版信息

Science. 2020 Dec 11;370(6522):1254-1255. doi: 10.1126/science.370.6522.1254.

DOI:10.1126/science.370.6522.1254

PMID:33303593

Abstract

摘要

相似文献

Tweaking genes with CRISPR or viruses fixes blood disorders.

Science. 2020 Dec 11;370(6522):1254-1255. doi: 10.1126/science.370.6522.1254.

Promising Strategies for Sickle Cell Disease and β-Thalassemia.

JAMA. 2021 Jan 12;325(2):121. doi: 10.1001/jama.2020.26232.

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.

N Engl J Med. 2021 Jan 21;384(3):252-260. doi: 10.1056/NEJMoa2031054. Epub 2020 Dec 5.

Gene therapy for sickle cell disease.

Lancet Haematol. 2016 Oct;3(10):e446. doi: 10.1016/S2352-3026(16)30130-2.

Molecular scissors cut in on stem cells.

Nat Med. 2019 Jun;25(6):864-866. doi: 10.1038/s41591-019-0467-6.

A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.

Stem Cells Transl Med. 2018 Jan;7(1):87-97. doi: 10.1002/sctm.17-0066. Epub 2017 Nov 21.

Genome Editing for Sickle Cell Disease: A Little BCL11A Goes a Long Way.

Mol Ther. 2017 Mar 1;25(3):561-562. doi: 10.1016/j.ymthe.2017.02.003. Epub 2017 Feb 9.

The Cas9 Hammer-and Sickle: A Challenge for Genome Editors.

CRISPR J. 2021 Feb;4(1):6-13. doi: 10.1089/crispr.2021.29120.fur.

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.

N Engl J Med. 2021 Jun 10;384(23):e91. doi: 10.1056/NEJMc2103481.

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.

N Engl J Med. 2021 Jun 10;384(23):e91. doi: 10.1056/NEJMc2103481.

引用本文的文献

CRISPR technology in human diseases.

MedComm (2020). 2024 Jul 29;5(8):e672. doi: 10.1002/mco2.672. eCollection 2024 Aug.

CRISPR in Public Health: The Health Equity Implications and Role of Community in Gene-Editing Research and Applications.

Am J Public Health. 2023 Aug;113(8):874-882. doi: 10.2105/AJPH.2023.307315. Epub 2023 May 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Tweaking genes with CRISPR or viruses fixes blood disorders.

Science. 2020 Dec 11;370(6522):1254-1255. doi: 10.1126/science.370.6522.1254.

Promising Strategies for Sickle Cell Disease and β-Thalassemia.

JAMA. 2021 Jan 12;325(2):121. doi: 10.1001/jama.2020.26232.

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.

N Engl J Med. 2021 Jan 21;384(3):252-260. doi: 10.1056/NEJMoa2031054. Epub 2020 Dec 5.

Gene therapy for sickle cell disease.

Lancet Haematol. 2016 Oct;3(10):e446. doi: 10.1016/S2352-3026(16)30130-2.

Molecular scissors cut in on stem cells.

Nat Med. 2019 Jun;25(6):864-866. doi: 10.1038/s41591-019-0467-6.

A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.

Stem Cells Transl Med. 2018 Jan;7(1):87-97. doi: 10.1002/sctm.17-0066. Epub 2017 Nov 21.

Genome Editing for Sickle Cell Disease: A Little BCL11A Goes a Long Way.

Mol Ther. 2017 Mar 1;25(3):561-562. doi: 10.1016/j.ymthe.2017.02.003. Epub 2017 Feb 9.

The Cas9 Hammer-and Sickle: A Challenge for Genome Editors.

CRISPR J. 2021 Feb;4(1):6-13. doi: 10.1089/crispr.2021.29120.fur.

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.

N Engl J Med. 2021 Jun 10;384(23):e91. doi: 10.1056/NEJMc2103481.

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.

N Engl J Med. 2021 Jun 10;384(23):e91. doi: 10.1056/NEJMc2103481.

引用本文的文献

CRISPR technology in human diseases.

MedComm (2020). 2024 Jul 29;5(8):e672. doi: 10.1002/mco2.672. eCollection 2024 Aug.

CRISPR in Public Health: The Health Equity Implications and Role of Community in Gene-Editing Research and Applications.

Am J Public Health. 2023 Aug;113(8):874-882. doi: 10.2105/AJPH.2023.307315. Epub 2023 May 18.